文献速递泌尿生殖腹部MR

全球前列腺磁共振成像质量的差异

Global Variation in Magnetic Resonance Imaging Quality of the Prostate.
PubMed 文献 · Radiology · 2023-01-01

PRIME试验质控阶段前瞻性评估71台扫描仪提交的355例前列腺多参数MRI,采用PI-QUAL评分,I期仅32%扫描仪达5分,接受反馈并修改方案后II期97%扫描仪达5分;动态对比增强序列最常不符合PI-RADS v2.1标准。

要点

  • PI-QUAL 5分(最佳)的比例从I期32%升至II期97%(62/64台),提示按反馈修改方案可显著提升图像质量。
  • I期71台中9台(13%)为3分(足够)、39台(55%)为4分(充分)、23台(32%)为5分(最佳),无1–2分(不可诊断)。
  • 不符合PI-RADS v2.1的序列以DCE最常见(48台中44台,92%),其次DWI(20台,42%)和T2WI(19台,40%)。

核心结论

  • 全球前列腺MRI采集参数存在明显质量差异,尤以DCE序列为著;使用PI-QUAL进行基本评估并修改MRI方案可带来质量的大幅提升。

研究设计与样本

  • PRIME前瞻性临床试验(注册号NCT04571840)质控阶段,每台扫描仪由中心提交连续5例检查和MRI方案(I期),2021年9月至2022年8月由两名泌尿生殖影像专家共识采用PI-QUAL 5分制评分(1–2不可诊断、3足够、4充分、5最佳)。

诊断标准与关键数值

  • PI-QUAL评分:1–2分为不可诊断,3分为足够,4分为充分,5分为最佳;I期71台扫描仪中3分9台(13%)、4分39台(55%)、5分23台(32%)。

临床应用与阅片要点

  • 对未达PI-QUAL 5分的扫描仪给予反馈并邀请使用修改后方案重新提交(II期),48台(71台中68%)接受反馈;II期17国36中心重新提交后62台(64台中97%)最终达PI-QUAL 5分。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

Background High variability in prostate MRI quality might reduce accuracy in prostate cancer detection. Purpose To prospectively evaluate the quality of MRI scanners taking part in the quality control phase of the global PRIME (Prostate Imaging Using MRI ± Contrast Enhancement) trial using the Prostate Imaging Quality (PI-QUAL) standardized scoring system, give recommendations on how to improve the MRI protocols, and establish whether MRI quality could be improved by these recommendations. Materials and Methods In the prospective clinical trial (PRIME), for each scanner, centers performing prostate MRI submitted five consecutive studies and the MRI protocols (phase I). Submitted data were evaluated in consensus by two expert genitourinary radiologists using the PI-QUAL scoring system that evaluates MRI diagnostic quality using five points (1 and 2 = nondiagnostic; 3 = sufficient; 4 = adequate, 5 = optimal) between September 2021 and August 2022. Feedback was provided for scanners not achieving a PI-QUAL 5 score, and centers were invited to resubmit new imaging data using the modified protocol (phase II). Descriptive comparison of outcomes was made between the MRI scanners, feedback provided, and overall PI-QUAL scores. Results In phase I, 41 centers from 18 countries submitted a total of 355 multiparametric MRI studies from 71 scanners, with nine (13%) scanners achieving a PI-QUAL score of 3, 39 (55%) achieving a score of 4, and 23 (32%) achieving a score of 5. Of the 48 (n = 71 [68%]) scanners that received feedback to improve, the dynamic contrast-enhanced sequences were those that least adhered to the Prostate Imaging Reporting and Data System, version 2.1, criteria (44 of 48 [92%]), followed by diffusion-weighted imaging (20 of 48 [42%]) and T2-weighted imaging (19 of 48 [40%]). In phase II, 36 centers from 17 countries resubmitted revised studies, resulting in a total of 62 (n = 64 [97%]) scanners with a final PI-QUAL score of 5. Conclusion Substantial variation in global prostate MRI acquisition parameters as a measure of quality was observed, particularly with DCE sequences. Basic evaluation and modifications to MRI protocols using PI-QUAL can lead to substantial improvements in quality. Clinical trial registration no. NCT04571840 Published under a CC BY 4.0 license. Supplemental material is available for this article. See also the editorial by Almansour and Chernyak in this issue.

来源:Radiology,查看原文。版权归原作者所有。

引用

  1. Giganti F, Ng A, Asif A, et al. Global Variation in Magnetic Resonance Imaging Quality of the Prostate. Radiology. 2023. PMID: 37815448. doi:10.1148/radiol.231130

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。